Acurx Pharmaceuticals, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Acurx Pharmaceuticals, Inc. now
Current reporting with the operating signal separated from the noise.
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
The story matters when it changes Acurx Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
The story matters when it changes Acurx Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Acurx Pharmaceuticals, Inc. (ACXP) Q3 2025 Earnings Call Transcript
Investors are testing whether Acurx Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update
The story matters when it changes Acurx Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Acurx Pharmaceuticals, Inc. (ACXP): Insider Were Buying In Q1 2025
The story matters when it changes Acurx Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Acurx Pharmaceuticals, Inc. Announces $1.1 Million Registered Direct Offering
The story matters when it changes Acurx Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest ACXP filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Acurx Pharmaceuticals, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →